411
Views
141
CrossRef citations to date
0
Altmetric
Original Article

Type I Interferon as a Link Between Innate and Adaptive Immunity through Dendritic Cell Stimulation

Pages 257-264 | Received 10 May 2003, Published online: 03 Aug 2009

References

  • Inaba, K., Metlay, J.P., Crowley, M.T., Witmer-Pack, M. and Steinman, R.M. (1990) "Dendritic cells as antigen presenting cells in vivo", International Reviews of Immunology, 6, 197–206.
  • Suss, G. and Shortman, K. (1996) "A subclass of dendritic cells kills CD4 T cells via fas/fas-ligand-induced apoptosis", Journal of Experimental Medicine, 183, 1789 — 1796.
  • Kronin, V., Winkel, K., Suss, G., Kelso, A., Heath, W., Kirberg, J., et al. (1996) "A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production", Journal of Immunology, 157, 38 19 — 3827.
  • Rissoan, MC., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., Waal, D., et al. (1999) "Reciprocal control of T helper cell and dendritic cell differentiation", Science, 283, 1183–1186.
  • Siegal, F.P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, PA., Shah, K., Ho, S., et al. (1999) "The nature of the principal type 1 interferon-producing cells in human blood", Science, 284, 1835 — 1837.
  • Kadowaki, N., Antonenko, S., Lau, J.Y.-N. and Liu, Y.J. (2000) "Natural interferon a//3-producing cells link innate and adaptive immunity", Journal of Experimental Medicine, 192, 219 — 225.
  • Cella, M., Facchetti, F., Lanzavecchia, A. and Colonna, M. (1999) "Plasmacytoid dendritic cells activated by influenza virus and CD4OL drive a potent TH1 polarization", Nature Immunology, 1, 305— 310.
  • Lutz, M.B., Sun, R.M., Niimi, M., Ogilvie, AL., Kukutsch, N.A., Rossner, S., et al. (2000) "Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo", European Journal of Immunology, 30, 1813–1822.
  • Reis e Sousa, C., Sher, A. and Kaye, P. (1999) "The role of dendritic cells in the induction and regulation of immunity to microbial infection", Current Opinion in Immunology, 11, 392— 399.
  • Reid, S.D., Penna, G. and Adorini, L. (2000) "The control of T cell responses by dendritic cell subsets", Current Opinion in Immunol-ogy, 12, 114–121.
  • Liu, Y.-J., Kanzler, H., Soumelis, V. and Gilliet, M. (2001) "Dendritic cell lineage, plasticity and cross-regulation", Nature Immunology, 2, 585 — 589.
  • Belz, G.T., Behrens, G.M.N., Smith, CM., Miller, J.F.A.P., Jones, C., Lejon, K., et al. (2002) "The CD8a± dendritic cell is responsible for inducing peripheral self-tolerance to tissue-asso-ciated antigens", Journal of Experimental Medicine, 196, 1099–1104.
  • Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., et al. (2002) "The CD8 ± dendritic cell subset selectively endocytoses dying cells in culture and in vivo", Journal of Experimental Medicine, 195, 1289 — 1302.
  • Martin, P., Martinez del Hoyo, G., Anjuere, F., Arias, C.F., Vargas, H.H., Fernandez-L, A., et al. (2002) "Characterization of a new subpopulation of mouse CD8a ± B220 ± dendritic cells endowed with type 1 interferon production capacity and tolero-genic potential", Blood, 100, 383–390.
  • Boonstra, A., Asselin-Paturel, C., Gilliet, M., Craffi, C., Trinchieri, G., Liu, Y.-J., et al. (2003) "Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation", Journal of Experimental Medicine, 197, 101–109.
  • Banchereau, J. and Steinman, R.M. (1998) "Dendritic cells and the control of immunity", Nature, 392, 245–252.
  • Gallucci, S., Lolkema, M. and Matzinger, P. (1999) "Natural adjuvants: Endogenous activators of dendritic cells", Nature Medicine, 5, 1249 — 1255.
  • Stahl, P.D. and Ezekowitz, R.A. (1998) "The mannose receptor is a pattern recognition receptor involved in host defense", Current Opinion in Immunology, 10, 50–55.
  • Sobanov, Y., Bernreiter, A., Derdak, S., Mechtcheriakova, D., Schweighofer, B., Duchler, M., et al. (2001) "A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex", European Journal of Immunology, 31, 3493 — 3503.
  • Barton, G.M. and Medzhitov, R. (2002) "Toll-like receptors and their ligands", Curr. Top. Microbiology and Immunology, 270, 81 — 92.
  • Balch, S.G., Greaves, D.R., Gordon, S. and McKnight, A.J. (2002) "Organization of the mouse macrophage C-type lectin (Mc) gene and identification of a subgroup of related lectin molecules", European Journal of Immunogenetics, 29, 61–64.
  • Peiser, L., Mukhopadhyay, S. and Gordon, S. (2002) "Scavenger receptors in innate immunity", Current Opinion in Immunology, 14, 123–128.
  • Ryan, E.J., Marshall, A.J., Magaletti, D., Floyd, H., Draves, K.E., Olson, N.E., et al. (2002) "Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule en-hances T cell secretion of IL-4", Journal of Immunology, 169, 5638 — 5648.
  • Geijtenbeek, TB., Engering, A. and Van Kooyk, Y. (2002) "DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology", Journal of Leukocyte Biology, 71, 921 — 931.
  • Turville, S.G., Cameron, P.U., Handley, A., Lin, G., Pohlmann, S., Doms, R.W., et al. (2002) "Diversity of receptors binding HIV on dendritic cell subsets", Nature Immunology, 3, 975–983.
  • Higashi, N., Fujioka, K., Denda-Nagai, K., Hashimoto, S., Nagai, S., Sato, T., et al. (2002) "The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells", Journal of Biological Chemistry, 277, 20686 — 20693.
  • Appelmelk, B.J., Van Die, I., Van Vliet, Si., Vandenbroucke-Grauls, CM., Geijtenbeek, T.B. and Van Kooyk, Y. (2003) "Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-grabbing non-integrin on dendritic cells", Journal of Immunology, 170, 1635 — 1639.
  • Isaacs, A. and Lindemann, J. (1957) "Virus interference. 1. The interferon", Proceedings of the Royal Society of London. Series B: Biological Sciences, 147, 258–273.
  • Roberts, R.M., Liu, L., Guo, Q., Leaman, D. and Bixby, J. (1998) "The evolution of type I interferons". Journal of Interferon and Cytokine Research, 18, 805–816.
  • LaFleur, D.W., Nardelli, B., Tsareva, T., Mather, D., Feng, P., Semenuk, M., et al. (2001) "Interferon-kappa, a novel type I interferon expressed in human keratinocytes", Journal of Biological Chemistry, 276, 39765 — 39771.
  • Oritani, K., Medina, K.L., Tomiyama, Y., Ishikawa, J., Okajima, Y., Ogawa, M., et al. (2000) "Limitin: an interferon-like cytokine that preferentially influences B-lymphocyte precursors", Nature Medicine, 6, 659–666.
  • Mogensen, K.E., Lewerenz, M., Reboul, J., Lutfalla, G. and Uze, G. (1999) "Type I IFN receptor: structure, function, and evolution of a family business", Journal of Interferon and Cytokine Research, 19, 1069 — 1098.
  • Goodbourn, S., Didcock, L. and Randall, R.E. (2000) "Interfer-ons: cell signalling, immune modulation, antiviral responses and virus countermeasures", Journal of General Virology, 81, 2341–2364.
  • Gresser, I., Tovey, M.G., Bandu, ME., Maury, C. and Brouty-boye, D. (1976) "Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infec-tion", Journal of Experimental Medicine, 144, 1305 — 1315.
  • Gresser, I., Tovey, M.G., Maury, C. and Bandu, M.T. (1976) "Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Maloney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses", Journal of Experimental Medicine, 144, 1316–1323.
  • Muller, U., Steinhoff, U., Reis, L.F., Hemmi, S., Pavlovic, J., Zinkernagel, R.M., et al. (1994) "Functional role of type land type II interferons in antiviral defense", Science, 264, 1918 — 1921.
  • Kirchner, H. (1984) "Interferons, a group of multiple lympho-kines", Springer Seminars in Immunopathology, 7, 347–374.
  • Belardelli, F., Gessani, S., Proietti, E., Locardi, C., Borghi, P., Watanabe, Y., Kawade, Y., et al. (1987) "Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons", Journal of General Virology, 68, 2203–2212.
  • Bogdan, C. (2000) "The function of type I interferons in antimicrobial immunity", Current Opinion in Immunology, 12, 419–424.
  • Youngner, J.S. and Stinebring, W.R. (1965) "Interferon appear-ance stimulated by endotoxin, bacteria, or viruses in mice pre-treated with Escherichia coli endotoxin or infected with Myco-bacterium tuberculosis", Nature, 208, 456–458.
  • Field, AK., Tytell, A.A., Lampson, G.P. and Hilleman, M.R. (1967) "Inducers of interferon and host resistance, II. Multi-stranded synthetic polynucleotide complexes", Proceedings of the National Academy of Sciences USA, 58, 1004–1010.
  • Maehara, N. and Ho, M. (1977) "Cellular origin of interferon induced by bacterial lipopolysaccharide". Infection and Immunity, 15, 78–83.
  • Ito, Y. and Hosaka, Y. (1983) "Component(s) of Sendai virus that can induce interferon in mouse spleen cells", Infection and Immunity, 39, 1019 — 1023.
  • Smith, EM., Johnson, H.M. and Blalock, J.E. (1983) "Staphylo-coccus aureus protein A induces the production of interferon-alpha in human lymphocytes and interferon-alpha/beta in mouse spleen cells", Journal of Immunology, OO, 130.
  • Tokunaga, T., Yano, O., Kuramoto, E., Kimura, Y., Yamamoto, T., Kataoka, T., et al. (1992) "Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of mycobacterium bovis BCG induce interferons and activate natural killer cells", Microbiology and Immunology, 36, 55 — 66.
  • Capobianchi, MR., Ankel, H., Ameglio, F., Paganelli, R., Pizzoli, P.M. and Dianzani, F. (1992) "Recombinant glycoprotein 120 of human immunodeficieny virus is a potent interferon inducer", AIDS Research and Human Retroviruses, 8, 575–579.
  • Laude, H., Gelfi, J., Lavenant, L. and Charley, B. (1992) "Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus", Journal of Virology, 66, 743–749.
  • Jacobs, B.L. and Langland, J.0. (1996) "When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA", Virology, 219, 339–349.
  • Ankel, H., Westra, D.F., Welling-Wester, S. and Lebon, P. (1998) "Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors", Virology, 251, 317 — 326.
  • Kanda, K., Kempkes, B., Bornkamm, G.W., von Gabain, A. and Decker, T. (1999) "The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines", Biological Chemistry, 380, 213–221.
  • Weeks, CE. and Gibson, Si. (1989) "Alpha interferon induction in human blood cell culture by immunomodulator candidate R-837", Journal of Interferon Research, 9, S215.
  • Chen, M., Griffith, B.P., Lucia, H.L. and Hsiung, G.D. (1988) "Efficacy of S26308 against guinea pig cytomegalovirus infection", Antimicrobial Agents and Chemotherapy, 32, 678–683.
  • Harrison, C.J., Jenski, L., Voychehovski, T. and Bernstein, D.I. (1988) "Modification of immunological responses and clinical disease during topical R-827 treatment of genital HSV-2 infec-tion", Antiviral Research, 10, 209–223.
  • Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., et al. (2002) "Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway", Nature Immunology, 3, 196–200.
  • Fitzgerald-Bocarsly, P. (1993) "Human natural interferon-alpha producing cells", Pharmacology and Therapeutics, 60, 39 — 62.
  • Grouard, G., Rissoan, M.C., Filgueira, L., Durand, I., Bancher-eau, J. and Liu, Y.J. (1997) "The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand", Journal of Experimental Medicine, 185, 1101–1111.
  • Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., et al. (1999) "Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type interferon", Nature Medicine, 5, 919 — 923.
  • Nakano, H., Yanagita, M. and Gunn, M.D. (2001) "CD1 lc ± B220 ± Gr-1 ± cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells", Journal of Experimental Medicine, 194, 1171 — 1178.
  • Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., et al. (2001) "The major type I interferon producing cells in the mouse ar immature antigen-presenting cells exhibiting plasmacytoid morphology", Nature Immunology, 2, 1144–1150.
  • Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Black-well, S., Ballas, Z.K., et al. (2001) "Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells", European Journal of Immunology, 31, 2154–2163.
  • O'Keefe, M., Hochrein, H., Vremec, D., Caminschi, I., Miller, J.L., Anders, M., et al. (2002) "Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8 ± dendritic cells only after microbial stimulus", Journal of Experimental Medicine, 196, 1307— 1319.
  • Ito, T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., et al. (2002) "Interferon-a and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets", Journal of Experimental Medicine, 195, 1507— 1512.
  • Gibson, Si., Lindh, J.M., Riter, T.R., Gleason, R.M., Rogers, L.M., Fuller, A.E., et al. (2002) "Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod", Cellular Immunology, 218, 74 —86.
  • Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P. and Jahnsen, F.L. (2001) "Plasmacytoid dendritic cells (natural interferon-/-producing cells) accumulate in cutaneous lupus erythematosus lesions", American Journal of Pathology, 159, 237— 243.
  • O'Keefe, M., Hochrein, H., Vremec, D., Scott, B., Hertzog, P., Tatarczuch, L., et al. (2003) "Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c ± DC! precursors", Blood, 101, 1453 — 1459.
  • Riffault, S., Carrat, C., Besnardeau, L., La Bonnardiere, C. and Charley, B. (1997) "In vivo induction of interferon-a in pig by non-infectious coronavirus: tissue localization and in situ phenotypic characterization of interferon-a-producing cells", Journal of General Virology, 78, 2483–2487.
  • Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., et al. (2001) "Toll-like receptor expression reveals CgG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12", European Journal of Immunology, 31, 3026 — 3037.
  • Kadowaki, N., Antonenko, S. and Liu, Y.-J. (2001) "Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD! lc — type 2 dendritic cell precursors and CD1 lc ± dendritic cells to produce type I IFN", Journal of Immunology, 166, 2291–2295.
  • Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. and Lanzavecchia, A. (1999) "Maturation, activation, and protection of dendritic cells induced by double-stranded RNA", Journal of Experimental Medicine, 189, 821–829.
  • Giacomini, E., Iona, E., Ferroni, L., Miettinen, M., Fattorini, L., Orefici, G., et al. (2001) "Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differ-ential cytokine gene expression that modulates T cell response", Journal of Immunology, 166, 7033–7041.
  • Remoli, ME., Giacomini, E., Lutfalla, G., Dondi, E., Orefici, G., Battistini, A., et al. (2002) "Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis", Journal of Immunology, 169, 366— 374.
  • Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P. and O'Keeffe, M. (2001) "Differential production of IL-12, IFN-and IFNI by mouse dendritic cell subsets", Journal of Immunol-ogy, 166, 5448 — 5455.
  • Foster, G.R., Germain, C., Jones, M., Lechler, RI. and Lombardi, G. (2000) "Human T cells elicit IFN- a secretion from dendritic cells following cell to cell interactions", European Journal of Immunology, 30, 3228–3235.
  • Paquette, R.L., Hsu, N.C., Kiertscher, S.M., Park, AN., Tran, L., Roth, M.D., et al. (1998) "Interferon-a and granulocyte-macro-phage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen presenting cells", Journal of Leukocyte Biology, 64, 358–367.
  • Santini, S.M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., et al. (2000) "Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice", Journal of Experimental Medicine, 191, 1777 — 1788.
  • Chen, X., Regn, S., Raffegerst, S., Kolb, H.J. and Roskrow, M. (2000) "Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia", British Journal of Haematology, 111, 596–607.
  • Parlato, S., Santini, S.M., Lapenta, C., Di Pucchio, T., Logozzi, M., Spada, M., et al. (2001) "Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities", Blood, 98, 3022— 3029.
  • Paquette, R.L., Hsu, N., Said, J., Mohammed, M., Rao, NP., Shih, G., et al. (2002) "Interferon-?induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo", Leukemia, 16, 1484–1489.
  • Buelens, C., Bartholome, E.J., Amraoui, Z., Boutriaux, M., Salmon, I., Thielemans, K., et al. (2002) "Interleukin-3 and interferon beta co-operate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory proper-ties", Blood, 99, 993–998.
  • Blanco, P., Palucka, AK., Gill, M., Pascual, V. and Banchereau, J. (2001) "Induction of dendritic cell differentiation by IFN- a in systemic lupus erythematosus", Science, 294, 1540— 1543.
  • Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K. and Fukuhara, S. (2001) "Differential regulation of human blood dendritic cell subsets by IFNs", Journal of Immunology, 166, 2961–2969.
  • McRae, B.L., Nagai, T., Semnani, R.T., van Seventer, J.M. and van Seventer, GA. (2000) "Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14( + ) precursors", Blood, 96, 210–217.
  • Wiesemann, E., Sonmez, D., Heidenreich, F. and Windhagen, A. (2002) "Interferon-?increases the stimulatory capacity of mono-cyte-derived dendritic cells to induce IL-13, IL-5 and IL-10 in autologous T-cells", Journal of Neuroimmunology, 123, 160— 169.
  • Lamer, AC., Petricoin, E.F., Nakagawa, Y. and Finbloom, D.S. (1993) "IL-4 attenuates the transcriptional activation of both IFN-alpha and IFN-gamma-induced cellular gene expression in monocytes and monocytic cell lines", Journal of Immunology, 150, 1944— 1950.
  • Dickensheets, H.L. and Donnelly, R.P. (1999) "Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons", Leukocyte Biology, 65, 307 — 312.
  • Luft, T., Pang, K.C., Thomas, E., Hertzog, P., Hart, D.N.J., Trapani, J., et al. (1998) "Type I IFNs enhance the terminal differentiation of dendritic cells", Journal of Immunology, 161, 1947–1953.
  • Wang, C., Al-Omar, H.M., Radvanyi, L., Banerjee, A., Bouman, D., Squire, J., et al. (1999) "Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-a", Experimental Hematology, 27, 1176–1184.
  • Padovan, E., Spagnoli, G.C., Ferrantini, M. and Heberer, M. (2002) "IFN-a2 induces IP-10/CXCLI0 and MIG/CXCL9 pro-duction in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8 ± effector T cells", Journal of Leukocyte Biology, 71, 669–676.
  • Luft, T., Luetjens, P., Hochrein, H., Toy, T., Masterman, K.A., Rizkalla, M., et al. (2002) "IFN-a enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells", Inter-national Immunology, 14, 367–380.
  • Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., et al. (2002) "Type I interferons produced by dendritic cells promote their phenotypic and functional activation", Blood, 99, 3263–3271.
  • Radvanyi, L.G., Banerjee, A., Weir, M. and Messner, H. (1999) "Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerate dendritic cell maturation from human peripheral blood mononuclear cells", Scandinavian Journal of Immunology, 50, 499 — 509.
  • Mattei, F., Schiavoni, G., Belardelli, F. and Tough, D.F. (2001) "IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation", Journal of Immunology, 167, 1179–1187.
  • Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, D.F. (2001) "Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo", Immunity, 14, 461–470.
  • Loetscher, M., Gerber, B., Loetscher, P., Jones, S.A., Piali, L., Clark-Lewis, I., et al. (1996) "Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes", Journal of Experimental Medicine, 184, 963–969.
  • Qin, S., Rottman, J.B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., et al. (1998) "The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions", Journal of Clinical Investigation, 101, 746–754.
  • Shields, P.L., Morland, CM., Salmon, M., Qin, S., Hubscher, S.G. and Adams, D.H. (1999) "Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver", Journal of Immunology, 163, 6236— 6243.
  • Park, M.K., Amichay, D., Love, P., Wick, E., Liao, F., Grinberg, A., et al. (2002) "The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo", Journal of Immunology, 169, 1433–1443.
  • Adema, G.J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., et al. (1997) "A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells", Nature, 387, 713 —717.
  • Ngo, V.N., Tang, H.L. and Cyster, J.G. (1998) "Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells", Journal of Experimental Medicine, 188, 181— 191.
  • Lehner, M., Felzmann, T., Cloth, K. and Holter, W. (2001) "Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells", Blood, 98, 736–742.
  • Litinskiy, MB., Bernardetta, N., Hilbert, D.M., He, B., Schaffer, A., Casali, P., et al. (2002) "DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL", Nature Immunology, 3, 822–829.
  • Hussien, Y., Sanna, A., Soderstrom, M., Link, H. and Huang, Y.M. (2001) "Glatiramer acetate and IFN-/3 act on dendritic cells in multiple sclerosis", Journal of Neuroimmunology, 121, 102–110.
  • McRae, B.L., Semnani, R.T., Hayes, M.P. and van Seventer, G.A. (1998) "Type I IFNs inhibit human dendritic cell IL-12 production and Thl cell development", Journal of Immunology, 160, 4298 — 4304.
  • Bartholome, E.J., Willems, F., Crusiaux, A., Thielemans, K., Schandene, L. and Goldman, M. (1999) "IFN-/3 interferes with the differentiation of dendritic cells from peripheral blood mono-nuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion", Journal of Interferon and Cytokine Research, 19, 471 — 478.
  • McRae, B.L., Beilfuss, B.A. and van Seventer, G.A. (2000) "IFN-/3 differentially regulates CD40-induced cytokine secretion by human dendritic cells", Journal of Immunology, 164, 23–28.
  • van Seventer, J.M., Nagai, T. and van Seventer, G.A. (2002) "Interferon-a differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells", Journal of Neuroimmunology, 133, 60–71.
  • Kalinski, P., Schuitemaker, J.H.N., Hilkens, C.M.U., Wierenga, E.A. and Kapsenberg, M.L. (1999) "Final maturation of dendritic cells is associated with impaired responsiveness to IFNI and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells", Journal of Immunology, 162, 3231–3236.
  • Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F. (2000) "Kinetics of dendritic cell activation: impact on priming of TH 1, TH2 and nonpolarized T cells", Nature Immunology, 1, 311 — 316.
  • Huang, Y.-M., Hussien, Y., Yarilin, D., 3Ciao, B.-G., Liu, Y.-J. and Link, H. (2001) "Interferon-beta induces the development of type 2 dendritic cells", Cytokine, 13, 264–271.
  • Braun, W. and Levy, H.B. (1972) "Interferon preparations as modifiers of immune responses", Proceedings of the Society for Experimental Biology and Medicine, 141, 769–773.
  • Chester, T.J., Paucker, K. and Merigan, T.C. (1973) "Suppression of mouse antibody producing spleen cells by various interferon preparations", Nature, 246, 92–94.
  • Brodeur, B.R. and Merigan, T.C. (1974) "Suppressive effect of interferon on the humoral immune response to sheep red blood cells in mice", Journal of Immunology, 113, 1319— 1325.
  • Brodeur, B.R. and Merigan, T.C. (1975) "Mechanism of the suppressive effect of interferon on antibody synthesis in vivo", Journal of Immunology, 114, 1323— 1328.
  • Strannegard, O., Larsson, I., Lundgren, E., Miornor, H. and Persson, H. (1978) "Modulation of immune responses in newborn and adult mice by interferon", Infection and Immunity, 20, 334 — 339.
  • Vignaux, F., Gresser, I. and Fridman, W.H. (1980) "Effect of virus-induced interferon on the antibody response of suckling and adult mice", European Journal Immunology, 10, 767–772.
  • De Maeyer, E. and De Maeyer-Guignard, J. (1980) "Host genotype influences immunomodulation by interferon", Nature, 284, 173 — 175.
  • Belardelli, F. and Gresser, I. (1996) "The neglected role of type I interferon in the T-cell response: implications for its clinical use", Immunology Today, 17, 369 — 372.
  • Proietti, E., Bracci, L., Puzelli, S., Di Pucchio, T., Sestili, P., De Vincenzi, E., et al. (2002) "Type I interferon as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model", Journal of Immunology, 169, 375–383.
  • Van Uden, J.H., Tran, C.H., Carson, D.A. and Raz, E. (2001) "Type I interferon is required to mount an adaptive response to immunostimulatory DNA", European Journal of Immunology, 31, 328 1 — 3290.
  • Cho, H.J., Hayashi, T., Datta, S.K., Takabayashi, K., Van Uden, J.H., Homer, A., et al. (2002) "IFN-aa promote priming of antigen-specific CD8 ± and CD4 ± T lymphocytes by immunos-timulatory DNA-based vaccines", Journal of Immunology, 168, 4907— 4913.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.